• About Us
  • Terms and Conditions
  • Privacy Policy
Sunday, June 26, 2022
MemoryWell
  • Home
  • About Us
  • Caregiving
    • Innovations in Caregiving
    • Millennial Caregivers
    • How-to’s for Caregiving
    • Faces of Caregiving
    • My Alzheimer’s Journey
    • Visual Stories
  • Sponsors & Members
  • Contact
  • Writers
No Result
View All Result
MemoryWell
  • Home
  • About Us
  • Caregiving
    • Innovations in Caregiving
    • Millennial Caregivers
    • How-to’s for Caregiving
    • Faces of Caregiving
    • My Alzheimer’s Journey
    • Visual Stories
  • Sponsors & Members
  • Contact
  • Writers
MemoryWell
No Result
View All Result
Home My Alzheimer's Journey

My Alzheimer’s Journey: Failing again

Although his symptoms were not acute enough to be accepted into a new study, Phil Gutis knows he's not cured of Alzheimer's

Phil Gutis by Phil Gutis
September 20, 2019
in My Alzheimer's Journey
2
Phil Gutis gets an infusion as part of a drug trial that eventually failed.

Phil Gutis gets an infusion as part of a drug trial that eventually failed.

414
VIEWS
Share on FacebookShare on Twitter

Three years ago, I was diagnosed with early-onset Alzheimer’s. I failed to score high enough on some fairly basic memory tests and therefore qualified for a drug trial. Subsequent genetic testing, MRIs and a PET scan supported that preliminary testing and I received 36 infusions of a test drug for Alzheimer’s.

This week, I failed again. But this time I failed to meet the basic threshold to qualify for an important longitudinal Alzheimer’s study. In other words, after very similar and basic memory tests, my brain was considered too healthy for me to participate in the Alzheimer’s Disease Neuroimaging Initiative 3.

So what happened? Am I cured of Alzheimer’s? Am I no longer living with mild cognitive impairment that typically leads to full blown Alzheimer’s? Should I now reject my monthly Social Security Disability checks and re-enter the workforce?

Unfortunately I don’t think that I’ve been cured of Alzheimer’s.

About an hour after returning home from the test facility, my husband Tim needed to remind me that we had once gone to an area dog park that a friend mentioned. And just moments later I was struggling to find the words to explain to Tim my feelings of being rejected from participating in the study.

Yes there is no doubt that I’ve recently been feeling better on a day-to-day basis. I’ve really kicked up my exercise levels and I’m convinced that the added blood flow to my brain is helping keep the Alzheimer’s monster in its cage.

But I’ve also had several memory and cognitive experiences in recent weeks that tell me that I’m not out of the woods. Episodes like completely forgetting that last year, Tim and I went to see our favorite political satirist in concert. Or becoming so confused trying to take a local train that I began to panic and needed to call my husband to come rescue me.

Phil Gutis had forgotten about seeing Randy Rainbow, but this photo brought back part of the memory.

Combine those experiences and other similar situations, and I have no doubt that something serious is indeed wrong with my brain.

Which leads me to another pressing question: how could eligibility for a major scientific study be based on incredibly skimpy testing? The key determinant today was how much of a five-sentence story I could remember. And how much of it I could remember after a 30-minute break.

Apparently I did too well in remembering the details of the story, which was also combined with knowing the answers to basic questions such as what day of the week it was. That was a bit of a cheat since while waiting for our appointment I repeatedly tried to get a news app on my iPad to reload because it was only showing Tuesday’s news and I thought it was Wednesday.

Based on that really skimpy testing, I was summarily rejected for a study that would have involved five years of annual visits to a clinic. For the first year, I had consented to three different PET scans and a lumbar puncture as well as a battery of memory testing. Over the next four years, I’d have had continued lumbar punctures, memory testing, MRIs and additional PET scans.

Tim and I agreed to all of this because we think it is absolutely critical to participate in research that can help unlock the mysteries of Alzheimer’s, a progressive neurological disease that destroys brain cells. Currently there is no cure and not even a significant treatment regimen for Alzheimer’s, a disease that is destroying the lives of 5.5 million people in the United States alone. (To say nothing of the millions of their caregivers who are also struggling mightily with the consequences of the disease.)

And the treatment situation just became worse: Donepezil, which is commonly known as Aricept, is one of the drugs typically recommended to try to slow down Alzheimer’s symptoms. But a recent new study found that Aricept may lead to a condition known as rhabdomyolysis, which causes muscle breakdown.

Trying new drugs

A year or so ago, worried about continued deterioration of my cognitive abilities and memory, I tried Aricept. Horrible nightmares, headaches and loss of bowel control quickly put an end to that experiment.

And then earlier this year the drug trial I had enrolled in was canceled because a “futility analysis” demonstrated that the test drug (called Aducanumab) was unlikely to work.

Since then, I’ve explored other possible trials but nothing has felt right, so I agreed to participate in the ADNI3 study, which is designed to “look at the relationship between clinical, cognitive, imaging, genetic and biomarker tests to understand the full spectrum of Alzheimer’s disease from its earliest stages.”

Data from the observational study will be used in the development of future research studies that will focus on the treatment of Alzheimer’s disease, which is exactly what I have long hoped to be part of.

So, what now? Recent events have proven to me that I do indeed have Alzheimer’s. Perhaps the rejection from the study should show me that I’m successfully resisting Alzheimer’s through exercise, weight loss and careful attention to various biomarkers such as blood pressure, cholesterol and blood sugar.

So I’ll continue to ramp up the exercise and spend more time on the indoor rower — I’m fairly close to having rowed a million meters since last December. And I’ll continue to count calories; I’m down about 20 pounds from my recent high of 224 last fall.

I will also keep advocating for additional Alzheimer’s research funding so scientists can finally begin to identify a treatment or cure for Alzheimer’s. That’s even if my moment-to-moment and day-to-day cognitive abilities preclude me from being part of it.

 

Phil Gutis

Phil Gutis is a former New York Times reporter and civil liberties and environmental advocate who was diagnosed with early-onset Alzheimer’s in 2016.

Previous Post

"All of Us" research program aims to bring diversity to clinical trials

Next Post

My Alzheimer's Journey: Choosing quality of life over quantity

Related Posts

Featured

My Alzheimer’s Journey: Dr. Oz reminds us to look for early signs of the disease

My Alzheimer's Journey

My Alzheimer’s journey: A train trip gone wrong

Phil Gutis had forgotten about seeing Randy Rainbow, but this photo brought back part of the memory.
My Alzheimer's Journey

My Alzheimer’s journey: Falling into the memory holes

Phil Gutis gets a scan wearing his unicorn slippers.
My Alzheimer's Journey

My Alzheimer’s journey: Looking for a unicorn

Rep. Brian Fitzpatrick, second from right, honors Phil Gutis, third from right, and members of his rowing club.
My Alzheimer's Journey

My Alzheimer’s journey: Should I have flossed more?

Phil Gutis with Abe, who died earlier this year.
My Alzheimer's Journey

My Alzheimer’s journey: A new dog fills a hole in the soul

Next Post

My Alzheimer's Journey: Choosing quality of life over quantity

Comments 2

  1. Jacquie Eder says:
    3 years ago

    Hi Phil,
    Thank you for sharing your journey. You are brave yet you show the struggle. I really admire your honesty.
    My sister in law was recently diagnosed with early onsite dementia at the age of 53. She and my brother live not too far from you in Buckingham PA. Do you do any local talks on the topic or would they be able to reach out to you?
    Jacquie

  2. Phil says:
    3 years ago

    Hi Jacquie. Thanks for reaching out. Jim and I chatted yesterday. I’m thinking about you and your family … Anything I can do to help, please let me know. I’m philgutis @ gmail.com and philgutis on Facebook.

    Phil

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts

Award winner Rashi Ranjan of San Jose with her grandmother Pushpam Kusum

Student writers bring humanity to dementia through essays

Resource List for Seniors

Award winner Rashi Ranjan of San Jose with her grandmother Pushpam Kusum

Young Authors Give Voice to Dementia

Our Sponsors

Embracing Carers is an initiative led by EMD Serono, in collaboration with leading caregiver organizations around the world, to increase awareness and action about the often-overlooked needs of caregivers.

Our Members

Do YOU give a care? is an effort led by The SCAN Foundation to highlight the caregiving role that more than 10 million millennials are playing in their families.

Life Stories

  • Life Stories
Life Stories

Meet Roberta (Randy) Tidmore

by Madeleine Joung

Read more
No Result
View All Result
MemoryWell

© 2019 MemoryWell, LLC. All Rights Reserved.

  • About Us
  • Terms and Conditions
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • About Us
  • Caregiving
    • Innovations in Caregiving
    • Millennial Caregivers
    • How-to’s for Caregiving
    • Faces of Caregiving
    • My Alzheimer’s Journey
    • Visual Stories
  • Sponsors & Members
  • Contact
  • Writers